Polypid
Sector: Healthcare & Life Sciences
About Polypid
Right Where Care Begins. PolyPid is an innovative biopharmaceutical company dedicated to improving patient outcomes by developing long-acting,
Products
D-PLEX100; PLEX Technology Platform
Incisional SSI prophylactic therapy engineered to extend protection throughout the critical postoperative recovery period.
Latest Company Updates
- PolyPid has received Certificate of GMP Compliance of a manufacturer
- PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal surgical site infections
- PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery
- PolyPid Announces Completion of $50 Million Series E-1 Financing
- PolyPid Announces Positive Top-line Results from Phase 2 Clinical Trial of D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Surgery